New lysine methyltransferase drug targets in cancer

Recent preclinical studies suggest that inhibitors of histone methyltransferases represent promising drug candidates for cancer therapy.

[1]  Yonghong Xiao,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[2]  Feng Liu,et al.  A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. , 2011, Nature chemical biology.

[3]  M. Hung,et al.  The role of EZH2 in tumour progression , 2011, British Journal of Cancer.

[4]  W. Sippl,et al.  Targeting epigenetic modifiers: Inhibitors of histone methyltransferases , 2010 .

[5]  Martin Dugas,et al.  Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2012, Nature Medicine.

[6]  A. Chase,et al.  Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.

[7]  Lars Bullinger,et al.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.

[8]  Shou-Jiang Gao,et al.  Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. , 2012, Cancer research.

[9]  Peter A. Jones,et al.  Epigenetic Modifications as Therapeutic Targets , 2010, Nature Biotechnology.

[10]  S. Schreiber,et al.  A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma , 2012, ACS chemical biology.

[11]  N. Keen,et al.  Structural basis of substrate methylation and inhibition of SMYD2. , 2011, Structure.

[12]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[13]  Steven Henikoff,et al.  Histone modification: cause or cog? , 2011, Trends in genetics : TIG.

[14]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[15]  Ryan D. Morin,et al.  Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin , 2010, Nature Genetics.